Ibotta (NYSE:IBTA) Price Target Lowered to $23.00 at The Goldman Sachs Group

Ibotta (NYSE:IBTAGet Free Report) had its target price reduced by equities research analysts at The Goldman Sachs Group from $26.00 to $23.00 in a report released on Thursday,Benzinga reports. The firm currently has a “sell” rating on the stock. The Goldman Sachs Group’s price target would indicate a potential downside of 12.05% from the company’s previous close.

Several other research firms also recently weighed in on IBTA. Wells Fargo & Company reiterated an “equal weight” rating and set a $30.00 price target (down previously from $60.00) on shares of Ibotta in a research note on Thursday, August 14th. Wall Street Zen upgraded Ibotta from a “sell” rating to a “hold” rating in a research note on Saturday, September 13th. Evercore ISI reiterated an “in-line” rating and set a $38.00 price target (down from $65.00) on shares of Ibotta in a research report on Thursday, August 14th. JMP Securities reaffirmed a “market perform” rating on shares of Ibotta in a research note on Thursday, August 14th. Finally, UBS Group decreased their target price on shares of Ibotta from $55.00 to $30.00 and set a “neutral” rating for the company in a research note on Thursday, August 14th. One analyst has rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Reduce” and an average price target of $32.57.

Get Our Latest Report on IBTA

Ibotta Trading Down 20.1%

Shares of NYSE:IBTA traded down $6.58 on Thursday, reaching $26.15. The company had a trading volume of 125,795 shares, compared to its average volume of 438,680. The firm has a market capitalization of $660.58 million, a PE ratio of 9.08 and a beta of -1.12. Ibotta has a 52-week low of $22.50 and a 52-week high of $76.99. The firm’s 50 day simple moving average is $29.63 and its 200-day simple moving average is $36.38.

Ibotta (NYSE:IBTAGet Free Report) last posted its earnings results on Wednesday, November 12th. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.22. Ibotta had a return on equity of 24.26% and a net margin of 26.24%.The company had revenue of $83.26 million for the quarter. During the same quarter last year, the firm earned $0.94 EPS. Ibotta’s revenue for the quarter was down 15.5% on a year-over-year basis. Ibotta has set its Q4 2025 guidance at EPS.

Institutional Trading of Ibotta

Hedge funds and other institutional investors have recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Ibotta in the first quarter worth approximately $25,000. CWM LLC raised its holdings in Ibotta by 225.2% in the 2nd quarter. CWM LLC now owns 943 shares of the company’s stock valued at $35,000 after buying an additional 653 shares during the period. Private Wealth Asset Management LLC purchased a new position in Ibotta during the second quarter worth about $37,000. Quantbot Technologies LP acquired a new stake in shares of Ibotta during the second quarter valued at about $66,000. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of Ibotta by 144.2% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,851 shares of the company’s stock worth $141,000 after acquiring an additional 2,274 shares during the last quarter.

Ibotta Company Profile

(Get Free Report)

Ibotta’s mission is to Make Every Purchase Rewarding. Our technology allows CPG brands to deliver digital promotions to over 200 million consumers through a single, convenient network called the Ibotta Performance Network (IPN). We are pioneers in success-based marketing: we only get paid when our client’s promotion results in a sale, not when a consumer merely views or clicks on the promotion.

Read More

Analyst Recommendations for Ibotta (NYSE:IBTA)

Receive News & Ratings for Ibotta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ibotta and related companies with MarketBeat.com's FREE daily email newsletter.